Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model. (Q34487826)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

0 references

1 reference

Europe PubMed Central

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alzheimer's disease

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Christopher Hyde

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jaime Peters

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mary Bond

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Gabriel Rogers

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rob Anderson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mike Jeffreys

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sarah Davis

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Praveen Thokala

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Tiffany Moxham

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

22 November 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

14-20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Estimating the relationship between disease progression and cost of care in dementia.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Management of Patients with Alzheimer’s Disease plus Cerebrovascular Disease: 12-Month Treatment with Galantamine

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Economic evaluation of donepezil in moderate to severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34487826&oldid=1474441251"